help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Simonian, S. X.
Right arrow Articles by Herbison, A. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Simonian, S. X.
Right arrow Articles by Herbison, A. E.
Endocrinology Vol. 139, No. 3 1420-1428
Copyright © 1998 by The Endocrine Society


ARTICLES

Estrogen-Dependent Ontogeny of Sex Differences in Somatostatin Neurons of the Hypothalamic Periventricular Nucleus1

Sharon X. Simonian, Hilary E. Murray, Glenda E. Gillies and Allan E. Herbison2

Laboratory of Neuroendocrinology, The Babraham Institute, Cambridge, United Kingdom CB2 4AT; and the Department of Neuroendocrinology, Division of Neuroscience, Imperial College Medical School (H.E.M., G.E.G.), London, United Kingdom W6 8RF

Address all correspondence and requests for reprints to: Dr. Allan E. Herbison, Laboratory of Neuroendocrinology, The Babraham Institute, Cambridge, United Kingdom CB2 4AT. E-mail: allan.herbison{at}bbsrc.ac.uk


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The sexually dimorphic profile of GH secretion is thought to be engendered by gonadal steroids acting in part on hypothalamic periventricular somatostatin (SOM) neurons. The present study set out to examine and characterize the development of sex differences in these SOM neurons. In the first series of experiments, we used in situ hybridization to examine SOM messenger RNA (mRNA) expression within the periventricular nucleus (PeN) of male and female rats on postnatal day 1 (P1), P5, and P10. Cellular SOM mRNA content was found to increase from P1 to P10 in both sexes (P < 0.01), but was 24% (P < 0.05) and 38% (P < 0.01) higher in males on P5 and P10, respectively. A second series of experiments examined the SOM peptide content of the PeN in developing rats and found increasing levels from P1 to P10, with a 44% higher SOM content in males compared with females on P10 (P < 0.05). The third series of experiments questioned the role of gonadal steroids in engendering sex differences in SOM mRNA expression by determining the effects of neonatal gonadectomy (GDX) and replacement of dihydrotestosterone or estradiol benzoate. The SOM mRNA content of PeN neurons in P5 males gonadectomized on the day of birth was the same as that in P5 females and was significantly reduced compared with that in sham-operated P5 males (P < 0.05). Male rats GDX on P1 and treated with estradiol benzoate from P1 to P5 had cellular SOM mRNA levels similar to those in intact males on P5, whereas dihydrotestosterone treatment had no effect. Treatment of intact males with an androgen receptor antagonist, cyproterone acetate, on P1 had no effect on cellular SOM mRNA on P5, whereas male rats given the aromatase inhibitor 1,4,6-androstatriene-3,17-dione from P1 to P5 had lower (P < 0.05) SOM mRNA levels than controls. In the final set of experiments, dual labeling immunocytochemistry showed that SOM neurons in the PeN of P5 rats did not contain estrogen receptor-{alpha}, but expressed androgen receptors in a sexually dimorphic manner. These results demonstrate that a sex difference in SOM biosynthesis, which persists into adulthood, develops between P1 and P5 in PeN neurons. Despite the absence of estrogen receptor-{alpha} in these neurons, the organizational influence of testosterone only occurs after its aromatization to estrogen.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
IN THE RAT, GH secretion from the anterior pituitary becomes markedly sexually dimorphic at puberty and remains so throughout adult life. Males have regular high amplitude GH pulses occurring at approximately 3- to 4-h intervals separated by low or undetectable baseline levels, whereas females exhibit irregular low amplitude GH pulses with an elevated baseline level (1, 2, 3). These patterns of GH secretion are generated for the most part by the asynchronous release of GH-releasing hormone (GHRH) and somatostatin (SOM) into the hypophyseal portal vasculature (4), and both of the relevant neural populations innervating the median eminence have now been shown to exhibit sex differences. The GHRH messenger RNA (mRNA) content and number of mediobasal hypothalamic GHRH neurons are greater in males than in females as is the SOM mRNA content of neurons in the periventricular nucleus (PeN) (5, 6, 7).

Like GH secretion, the described sex differences in SOM and GHRH neurons are determined by perinatal organizational and adult activational influences of gonadal steroids. Neonatal gonadectomy of the male rat results in feminization of the GH secretory profile (8, 9) as well as SOM mRNA expression in the PeN and GHRH cell number and mRNA content (10). Equally, perinatal and adult administration of testosterone to female rats masculinizes the GHRH and SOM neuronal cell populations and provides a partial masculinization of GH secretion (10, 11). Such observations suggest that the perinatal testosterone surge in the rat (12) organizes the SOM and GHRH neurons so that testosterone can act in the postpubertal male to establish the male pattern of GH secretion.

The SOM neurons of the PeN play a major role in determining the profile of GH secretion (3, 4), and the elevated SOM mRNA expression in these cells in the male is thought to be related to the low baseline GH concentrations found in this sex (3, 7). The stimulatory effect of gonadal steroids on the SOM mRNA content of neurons in the PeN of the adult male has been shown to depend upon an androgen receptor (AR)-mediated mechanism (13, 14) and may represent a direct action of testosterone on SOM neurons as they express ARs in a sexually dimorphic fashion (15). However, the organizational influences of testosterone on this cell population are less clear. For example, SOM neurons differentiate relatively early during embryogenesis (16), and it is not known at what time sex differences first appear within the PeN population. Argente and co-workers (6) demonstrated that SOM mRNA expression was elevated in males on postnatal day 10 (P10), but earlier time points were not examined. Furthermore, although it is established that testosterone acts through the AR to regulate SOM mRNA expression in the adult (13, 14), it is not clear whether this is also the case during development, when testosterone often engenders sex differences in the brain after its aromatization to estrogen (17).

Hence, in the present series of studies we set out to describe and characterize the development of sex differences in the SOM neurons of the PeN, first by examining the time point at which differences in SOM mRNA and peptide content first appear between males and females, and second by establishing the gonadal steroid dependence of this ontogenetic dimorphism and investigating the manner in which it may be exerted on developing SOM neurons.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Animals
Time-mated pregnant Wistar rats were housed individually and maintained in a controlled environment (lights on for 14 h, off for 10 h; 22 C), with food and water freely available. Animals were monitored twice daily until they littered, and the birth date was designated P1. Immediately after birth, pups were housed so that each experimental group comprised a dam with eight male or female pups. All procedures were conducted in accordance with United Kingdom Home Office requirements for animal scientific procedures.

Exp 1: profile of neonatal SOM mRNA expression
Male and female rats (n = 6 for each sex and group) were killed on the afternoon of P1, P5, or P10. Animals were decapitated, and brains were quickly removed. Blocks containing the hypothalamus were rapidly frozen on dry ice and stored at -70 C. Fresh-frozen sections (15 µm thick) were cut in the coronal plane (plates 22–26 of Swanson) on a cryostat (Bright, Huntingdon, UK) and thaw-mounted onto Vectabond-coated slides (Vector Laboratories, Peterborough, UK). Sections were kept at -70 C until used.

For in situ hybridization experiments, an antisense oligonucleotide complimentary to bases 310–339 of the rat prepro-SOM complementary DNA (which codes for part of SOM-14) was synthesized. This nucleotide sequence has been used previously to detect SOM mRNA-expressing cells in the rat brain (18). The probe was 3'-end labeled with [{alpha}-35S]deoxy-ATP (1000–1500 Ci/mmol; New England Nuclear, Boston, MA) using terminal deoxynucleotidyl transferase (50 U; Pharmacia, St. Albans, UK), resulting in a specific activity of approximately 109 cpm/µg. The radiolabeled probe was purified by filtration on a Sephadex G-50 column. Frozen sections were warmed to room temperature with a hair dryer and then fixed with 4% paraformaldehyde in 0.1 M phosphate buffer for 20 min. Fixed sections were rinsed in 0.1 M PBS treated with 0.1% diethylpyrocarbonate. Sections were then dehydrated though 70%, 80%, 90%, 95%, and 100% alcohol and allowed to air-dry. Two hundred and fifty microliters of hybridization buffer [4 x saline sodium citrate (SSC), 50% deionized formamide, 10% dextran sulfate, 1 x Denhardt’s solution, 250 µl/ml sheared salmon testis DNA, and 0.3% ß-mercaptoethanol] containing the 35S-labeled SOM probe (28 fmol/µl equivalent to 2 x 103 cpm/µl) were then applied to each slide containing six brain sections. Hybridization was carried out in humidified chambers at 37 C overnight. Hybridized sections were then washed in 1 x SSC at room temperature, three times in 1 x SSC at 55 C (30 min each), and again in 1 x SSC for 1 h at room temperature. All of the 1 x SSC solutions contained 0.001% ß-mercaptoethanol. After a quick wash in water, hybridized sections were placed in a 300 mM ammonium acetate-70% ethanol solution and then absolute alcohol for 30 sec each and allowed to air-dry before dipping in Ilford K-5 nuclear track emulsion and exposed for 2–4 days in light-tight boxes. At the appropriate exposure time, as determined by test slides, all slides were photodeveloped with Ilford phenisol (diluted 1:5 in distilled water, 5 min at 20 C). After developing, slides were counterstained lightly with methylene blue and coverslipped. Hybridization specificity was assessed by use of competition experiments in which radiolabeled probes were hybridized to sections in the presence of an excess (25-fold) of unlabeled probe.

For the analysis of SOM mRNA expression, slides were numbered randomly so that the operator was unaware of the experimental group. Using a Seescan (Cambridge, UK) analyzer coupled to a Leica Orthoplan microscope (Milton Keynes, UK), a quantitative analysis of somatostatin mRNA expression was undertaken by determining, under brightfield illumination, the relative silver grain density overlying individual cells in the PeN and central nucleus of the amygdala (CNA) at the coronal levels equivalent to plates 23 and 26 of the Swanson atlas (19), respectively. For each animal, 30 cells were analyzed in each region from 1–3 sections. For the PeN, the field of image analysis was positioned over the dorsal aspect of the periventricular area, and all positively hybridized cells (typically 6–8 cells) within the field of view were analyzed. The field of image analysis was then moved caudally, and an additional set of cells was analyzed until either no more hybridized cells could be found and analysis of another section was begun, or a total of 30 cells had been reached. Previous studies in our laboratory have shown that SOM neurons in the dorsal and ventral aspects of the PeN exhibit an identical pattern of silver grain density and that this responds to gonadal steroids in an identical fashion (Simonian, S. X., and A. E. Herbison, unpublished observations). Initially, the number of silver grains overlying cells in the excess unlabeled probe control were determined, and in experimental sections, only those cells expressing numbers of silver grains greater than 5 times the control value were used for analysis. For each rat and region, an average silver grain count per µm2/cell was determined, and these values were combined to give experimental group means. In addition, frequency histograms were constructed by allocating the relative proportions of PeN cells expressing different numbers of silver grains per µm2 in 0.1-U bins. All values are expressed as the mean ± SEM, and statistical comparisons were made using the nonparametric Mann-Whitney U test. P < 0.05 was considered statistically significant.

Exp 2: profile of neonatal SOM peptide content in PeN
P1, P5, and P10 male and female pups (n = 6 for each sex and group) were decapitated, their brains were quickly removed, and tissue was cut so that a block containing the hypothalamus was mounted on a cutting platform ready for sectioning with a Vibratome. The hypothalamic block was immersed in a bath of ice-cold Krebs buffer (pH 7.4), and coronal brain slices 300 µm thick were cut from the level of the optic chiasm through to the mediobasal hypothalamus. The coronal brain slice containing the PeN at the coronal level equivalent to that of plate 23 of Swanson (19) was selected from each animal, and a unilateral punch including all of the PeN was taken. The thickness of the coronal slice in P1 rats was reduced to 200 µm to ensure that SOM cell populations outside the PeN were excluded from the punch, which extended in all cases from the level of the fornix to just above the optic chiasm in the dorso-ventral orientation and included all of the periventricular region out to the level of the fornix medio-laterally. Our previous immunocytochemical and in situ hybridization experiments had shown that the SOM neurons sampled by this method are almost exclusively from the PeN population. Tissue punches were collected in 10 mM HCl on ice, and after homogenization and centrifugation, the supernatant was collected and stored at -80 C. The SOM content was later measured in duplicate by RIA as described previously (20). The sensitivity of the assay was 5–10 pg/ml, with intra- and interassay coefficients of variation of 3.5% and 7.2%, respectively. All values are expressed as the mean ± SEM, and statistical comparisons were made using Student’s t test. P < 0.05 was considered statistically significant.

Exp 3: effects of gonadal steroid manipulations on neonatal SOM mRNA
Gonadectomy (GDX) and SILASTIC brand (Dow Corning, Midland, MI) capsule implantation were performed within 12 h of birth under cold anesthesia. Neonates were placed on ice, the gonads were removed, and the abdominal incision was closed with surgical silk before the pups were warmed to 37 C and returned to their mothers. Sham operations involved anesthetizing the pups and making incisions as described for GDX, but closing the wound without removal of the gonads.

Four experimental manipulations were undertaken. 1) Male rats were GDX (n = 6) and killed alongside sham-treated males (n = 4) and unoperated females (n = 8) on the afternoon of P5. 2) Male rats were GDX and given daily sc (50 µl) injections of ethyl oleate vehicle alone (n = 5) or vehicle containing dihydrotestosterone (DHT; 50 µg/50 µl oil; n = 5) or estradiol benzoate (EB; 1 µg/50 µl oil; n = 5) and killed with sham-treated males (n = 6) on the afternoon of P5. 3) Male rats received sc injections of either ethyl oleate (50 µl; n = 6) or cyproterone acetate (CP; 500 µg/50 µl oil; n = 5) within 12 h of birth and were killed on the afternoon of P5. 4) Male rats received a sc SILASTIC capsule implant (Sani-tech, Havant, UK; id, 1.02 mm; od, 2.18 mm; length, 5 mm) containing either crystalline 1,4,6-androstatriene-3,17-dione (ATD; Steraloids, La Jolla, CA; n = 6) or SILASTIC glue (n = 6). Rats were then killed on the afternoon of P5. Each of these treatment regimens has been described previously for the manipulation of gonadal steroid levels in the neonatal rat (21, 22, 23). Animals were decapitated, and brains were quickly removed and processed for in situ hybridization as described above.

Exp 4: estrogen receptor (ER) and AR expression by neonatal SOM neurons
Male (n = 5) and female (n = 4) neonates were anesthetized with Avertin (2% tribromethanol, 1 ml/100 g BW, ip) on P5 and perfused transcardially with heparinized 0.9% saline followed by approximately 4 ml of a 4% paraformaldehyde 0.1 M phosphate buffer (pH 7.6) solution. Brains were removed, postfixed for 1 h at room temperature in the same fixative, and cryoprotected overnight in a 30% sucrose/0.05 M Tris-buffered saline (TBS) solution. Coronal sections (25 µm thick) containing the PeN were cut the next day on a freezing microtome and collected into TBS as three sets of sections.

After washing in a 40% methanol-TBS solution containing 1% H2O2, one set of sections was incubated in a monoclonal mouse antiserum directed against the N-terminal domain of human ER{alpha} (ID5, 1:10, gift from G. Delsol, Toulouse, France), and another set of sections was incubated in a polyclonal rabbit antiserum directed against the N-terminal region of the androgen receptor (AR; PG-21-18, 1.0 µg/ml, gift from Dr. G. Prins, Chicago, IL) for 40 h at 4 C. This was followed by either biotinylated horse antimouse Igs (1:200; Vector) or biotinylated goat antirabbit Igs (1:200; Vector) and the Vectastain Elite kit (1:50; Vector) for 90 min each at room temperature. Immunoreactivity was visualized using a nickel-enhanced 3,3'-diaminobenzidene tetrachloride (DAB) procedure. The production and specificity of the ER and AR antibodies were reported previously (15, 24, 25, 26).

Double staining was carried out as described previously (15, 27) by washing ER- and AR-stained sections in a 40% methanol-TBS solution containing 1% H2O2, washing in TBS, and then placing sections in a polyclonal rabbit antiserum specific for somatostatin (1:3000; gift from F. Vandesande, Belgium) for 40 h, followed by incubation in biotinylated goat antirabbit Igs (1:200; Vector) and streptavidin-biotinylated horseradish peroxidase complex (1:200, Amersham) each for 90 min at room temperature. Somatostatin immunoreactivity was visualized using the glucose oxidase technique with DAB only. The production and specificity of the SOM antiserum were reported previously (15, 27, 28). All primary and secondary antibodies were diluted in TBS-0.3% Triton-0.25% BSA, whereas tertiary Igs were diluted in TBS alone.

An analysis of double labeled brain sections was undertaken in the PeN. Brain sections at the level of the anterior hypothalamus containing the greatest numbers of SOM-immunoreactive cell profiles in the PeN were selected, and cell counts were made from a minimum of three sections per animal. The number of DAB-stained cell profiles with and without black nuclear immunoreactivity was counted in the PeN of each section, and these values were averaged for each animal and combined to give the mean ± SEM for each group.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Exp 1: profile of neonatal SOM mRNA expression
Substantial numbers of cells expressing SOM mRNA were detected in the periventricular region extending from the preoptic area through to the mediobasal hypothalamus (Fig. 1Go). Elsewhere in these sections, the SOM hybridization signal was strong within neurons of the amygdala, hippocampus, and cortex (18). Silver grain clusters over cells were absent when sections underwent hybridization in the presence of an excess of unlabeled probe.



View larger version (125K):
[in this window]
[in a new window]
 
Figure 1. Methylene blue counterstained sections of intact male (A) and female (B) P10 brains through the PeN after hybridization with a 35S-labeled somatostatin oligonucleotide. Note that P10 males have significantly more silver grains clustered over cells than P10 females. 3v, Third ventricle. Scale bar = 20 µm.

 
The numbers of silver grains per µm2/cell overlying PeN cells increased from P1 to P10 in both male and female rats [male, 0.50 ± 0.02 (P1), 0.95 ± 0.06 (P5), 2.27 ± 0.23 (P10); female, 0.56 ± 0.03 (P1), 0.75 ± 0.03 (P5), 1.35 ± 0.17 (10) silver grains/µm2·cell] and was 24% (P < 0.05) and 38% (P < 0.01) higher in males than in females on P5 and P10, respectively (Fig. 2AGo). Histograms of the relative proportions of cells expressing different levels of silver grains per µm2/cell revealed normally distributed populations of cells at each developmental age and sex (not shown). The relative hybridization signal in the CNA increased from P1 to P10 in both male and female rats (male, 1.10 ± 0.05 (P1), 1.45 ± 0.09 (P5), 1.79 ± 0.05 (P10); female, 1.16 ± 0.06 (P1), 1.35 ± 0.08 (P5), 1.95 ± 0.07 (P10) silver grains/µm2·cell), but was not sexually dimorphic at any age (Fig. 2BGo).



View larger version (33K):
[in this window]
[in a new window]
 
Figure 2. Cellular SOM mRNA content (as reflected by mean silver grains per µm2/cell ± SEM) of neurons in the PeN (A) and CNA (B) of P1, P5, and P10 male and female rats. SOM mRNA expression increased from P1 to P10 in both male and female rats in both brain areas (by ANOVA, P < 0.001). *, P < 0.05; **, P < 0.01 (by Mann-Whitney U test).

 
Exp 2: profile of neonatal SOM peptide content in PeN
The SOM peptide content of PeN punches from male and female rats was greatly elevated between P1 and P5, but was not significantly different between the sexes (males, 185 ± 1 and 1505 ± 176; females, 214 ± 14 and 1566 ± 176 pg SOM/PeN punch on P1 and P5, respectively; Fig. 3Go). Although SOM peptide content was not increased further between P5 and P10 in females (1420 ± 168 pg SOM/PeN punch on P10), it was elevated further in males and was approximately 44% higher in males (2056 ± 85 pg SOM/PeN punch) than in females on P10 (P < 0.05; Fig. 3Go).



View larger version (54K):
[in this window]
[in a new window]
 
Figure 3. SOM peptide content of PeN punches of male and female rats on P1, P5, and P10. PeN SOM content was elevated between P1 and P5 in both sexes and was significantly higher in males on P10. *, P < 0.05, by Student’s t test.

 
Exp 3: effects of gonadal steroid manipulations on neonatal SOM mRNA
Male rats GDX within 12 h of birth were examined on P5 and had significantly lower silver grain densities than sham-treated P5 males (0.62 ± 0.05 and 0.83 ± 0.04 silver grains/µm2·cell respectively; P < 0.05), but levels similar to those in intact P5 females (0.58 ± 0.04 silver grains/µm2·cell; Fig. 4AGo). Hybridization signal in the CNA of the same brain sections was not different among sham-treated males (1.09 ± 0.07 silver grains/µm2·cell), GDX males (1.20 ± 0.07 silver grains/µm2·cell), and intact females (1.14 ± 0.05 silver grains/µm2·cell) (data not shown).



View larger version (27K):
[in this window]
[in a new window]
 
Figure 4. Cellular SOM mRNA levels (as reflected by mean silver grains per µm2/cell ± SEM) in PeN neurons of P5 rats. A, Effect of gonadectomy is shown by comparing female, sham-treated male, and GDX male rats. B, Effect of gonadal steroid replacement to GDX males is shown by comparing intact males with GDX males treated with oil, DHT, or EB. Gonadectomy of newborn male rats resulted in female SOM mRNA levels on P5. DHT had no effect on SOM mRNA levels, whereas EB resulted in SOM mRNA levels indistinguishable from those in intact males, but not significantly different (P > 0.05) from those in oil-treated GDX rats. *, P < 0.05, by Mann-Whitney U test.

 
The PeN neurons of GDX males receiving oil or DHT injections exhibited significantly less hybridization signal (0.41 ± 0.05 and 0.40 ± 0.01 silver grains/µm2·cell, respectively; P < 0.05) than sham-treated males killed on P5 (0.54 ± 0.01 silver grains/µm2·cell; Fig. 4BGo). GDX males treated with EB displayed silver grain levels per cell (0.52 ± 0.07 silver grains/µm2·cell) comparable to those in sham-treated males (0.54 ± 0.01 silver grains/µm2·cell), although they failed to reach a statistically significant increase compared with those in oil-treated GDX males (Fig. 4BGo). This resulted from a single estrogen-treated animal failing to show an increase in hybridization signal. Gonadectomy or neonatal steroid replacements had no effect on hybridization signal in the CNA of the male rat (sham GDX, 0.92 ± 0.03; GDX + oil, 0.94 ± 0.03; GDX + DHT, 0.93 ± 0.05; GDX + EB, 0.97 ± 0.08 silver grains/µm2·cell).

Treatment of intact male rats on the day of birth with the androgen receptor antagonist CP had no effect on relative SOM mRNA expression in either the PeN (male, 0.75 ± 0.03; male + CP, 0.78 ± 0.07 silver grains/µm2/cell; Fig. 5Go) or CNA (male, 0.99 ± 0.06; male + CP, 1.18 ± 0.07 silver grains/µm2·cell) of P5 rats.



View larger version (46K):
[in this window]
[in a new window]
 
Figure 5. Cellular SOM mRNA levels (as reflected by mean silver grains per µm2/cell ± SEM) in PeN neurons of P5 males treated with an AR antagonist, CP, on P1 or an aromatase inhibitor, ATD, for the first 5 days of postnatal life. CP had no effect on SOM mRNA levels, whereas ATD-treated males had significantly lower cellular SOM mRNA expression within the PeN compared with intact males (*, P < 0.05). The differences in absolute silver grain numbers per cell between the CP and ATD experiments arise from the inclusion of the two experiments in different in situ hybridization runs.

 
Treatment of intact male rats with the aromatase inhibitor ATD from the day of birth to P5 resulted in a significantly lower cellular silver grain density in the PeN (0.84 ± 0.03) of P5 rats compared with that in males treated with vehicle alone (1.00 ± 0.05; P < 0.05; Fig. 5Go). No difference was seen in the CNA between these groups (male 1.74 ± 0.02; male + ATD, 1.70 ± 0.04 silver grains/µm2·cell).

Exp 4: ER and AR expression by neonatal SOM neurons
Cells immunoreactive for SOM were identified throughout the coronal brain sections as described previously in the neonatal rat brain (29). Within the hypothalamus of P5 rats, prominent cell body staining was observed in the PeN, and immunoreactive cells were also detected in ventrolateral aspects of the ventromedial nucleus (VMNvl). Cell counts revealed no significant difference in the number of SOM-immunoreactive cell profiles detected within the PeN of P5 rats (males, 122 ± 3; females, 136 ± 6 profiles/section).

Immunoreactivity for the ER and AR appeared as a black nuclear reaction product restricted to the nucleus of the cell. In some cases, ER staining was also detected in the cytoplasm of cells exhibiting strong nuclear staining. Cells exhibiting ER immunoreactivity were found in high density within the medial preoptic nucleus, bed nucleus of the stria terminalis, arcuate nucleus, and VMNvl, whereas smaller populations of cells were identified within the PeN extending from the preoptic area to the mediobasal hypothalamus. Cells exhibiting AR immunoreactivity within the hypothalamus were found in the medial preoptic nucleus and arcuate nucleus, and in lower numbers within the PeN. Double labeled cells were identified as cells displaying both brown cytoplasmic (somatostatin immunoreactivity) and black nuclear staining (ER or AR immunoreactivity; Fig. 6Go). Within the PeN, only a small minority of SOM neurons was found to express ER immunoreactivity, and this amounted to less than 0.3% of all SOM neurons (Fig. 6AGo; 0.27 ± 0.12% in P5 females; 0.12 ± 0.08% in males). This was not due to a failure of the double labeling procedure, as many cells coexpressing SOM and ER immunoreactivities were found in the VMNvl (Fig. 6BGo), and numerous single labeled ER-immunoreactive cells were found adjacent to the SOM neurons in the PeN in both sexes (Fig. 6AGo). In contrast, a substantial number of SOM neurons in the PeN expressed AR immunoreactivity (Fig. 6Go, C and D) in the P5 male rat (42.5 ± 0.7 double labeled profiles/section representing 34 ± 7% of all SOM neurons), and this was significantly greater (P < 0.05, by Mann-Whitney U test) than the number of SOM plus AR cells encountered in the female PeN (2.0 ± 1.1 double labeled profiles/section, representing 3 ± 1% of all SOM neurons; Fig. 7Go).



View larger version (145K):
[in this window]
[in a new window]
 
Figure 6. Photomicrographs of cells in the PeN (A, C, and D) and ventrolateral ventromedial nucleus (VMN; B) of a P5 male rat after double labeling for SOM (brown staining) and ER{alpha} (A and B; black nuclei) or the AR (C and D; black nuclei). Note that SOM and ER immunoreactivities are not colocalized in the PeN (A), but are in the VMN (B). Numerous SOM neurons coexpress AR immunoreactivity in the PeN (C and D). Arrows indicate double labeled cells in the high power photomicrographs (B and D). The inset in C shows a high power view of the double labeled cell to the left in C. Scale bars in A and C, 25 µm; those in B and D, 10 µm.

 


View larger version (33K):
[in this window]
[in a new window]
 
Figure 7. Percentage (±SEM) of SOM cells in the PeN exhibiting nuclear immunoreactivity for ERs or ARs in male and female rats on P5.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
We report here that a male-dominant sex difference in SOM mRNA and peptide content develops in the PeN between P1 and P5 in the rat. Previous studies have shown that SOM peptide content and mRNA expression increase within the whole hypothalamus during the first week of life (16, 30). We now extend these observations to demonstrate that a substantial increase in SOM mRNA occurs within PeN neurons themselves over this period. As a sex difference in SOM peptide content also becomes evident on P10, the sexually dimorphic SOM mRNA expression seems likely to be of functional significance to SOM biosynthesis within PeN neurons. We demonstrate that this sex difference is engendered by estrogen derived from testosterone within the first few neonatal days in the male, and others have shown it to persist from P10 into adulthood (6). A similar developmental increase in SOM mRNA expression was detected within the CNA, but no evidence was found for any sexual dimorphism or effect of neonatal gonadal steroid manipulation. Thus, the sexually differentiating action of testosterone appears to be targeted to SOM neurons of the PeN and not generalized to all SOM-expressing cells in brain.

Gonadal steroid induction of SOM sex difference in PeN
We demonstrate that cellular SOM mRNA expression in P5 males is reduced to female levels when male rats are GDX within 12 h of birth. This result indicated the gonadal steroid dependence of the SOM mRNA sexual dimorphism, and a subsequent investigation was designed to determine which gonadal steroid receptor was involved. Although the neonatal administration of estradiol to GDX male rats elevated SOM mRNA expression to levels similar to those observed in intact male rats, it did not, due to a single animal, increase transcript content significantly compared with that in oil-treated GDX males. In a further study we used ATD to prevent the aromatization of testosterone to estradiol and found that neonatal ATD treatment reduced the SOM mRNA expression of PeN neurons in all males to female levels. Together these observations provide clear evidence that SOM mRNA expression is sexually differentiated in PeN neurons through an ER-mediated mechanism. In two separate experiments involving administration of the nonaromatizable androgen DHT to GDX males and use of an AR antagonist in intact males, we could find no evidence for a role of ARs in this process. This is unlikely to result from a false negative, as the exact same neonatal ATD and DHT protocols have been used by others to demonstrate the AR dependence of other mRNAs in the developing rat brain (22, 23). Hence, we conclude that the SOM neurons of the PeN are sexually differentiated by estrogen after the aromatization of testosterone over P1 to P5 when males have relatively high levels of circulating testosterone concentrations (12). This critical period of sensitivity and involvement of ERs is similar to that reported for a number of morphological and biochemical sex differences observed within the preoptic area of the rat (21, 31, 32, 33).

Mechanism of estrogen action
Although it is clear that ERs are involved in generating the sex differences in SOM expression by PeN neurons in neonatal rats, the mechanisms and pathways used by estrogen are unclear. Our double labeling immunocytochemical studies show an almost complete absence of ER{alpha} immunoreactivity in SOM neurons of the PeN in both male and female P5 rats. We have similarly failed to detect ER{alpha} immunoreactivity in SOM neurons of the PeN of adult rats (27). Hence, it would seem that estrogen does not influence SOM neurons in any direct manner involving ER{alpha} during postnatal development. The recent discovery of ERß (34, 35) raises the interesting possibility that the sexually differentiating actions of estrogen on SOM neurons in the PeN may occur directly through this receptor. Whether this is the case awaits further investigation. Although recent data suggest that ERß mRNA is indeed expressed in the PeN of neonatal rats (DonCarlos, L., personal communication), using one of the available antibodies we have failed to detect ERß immunoreactivity in SOM neurons of the adult rat PeN despite showing its presence in numerous oxytocin neurons of the caudal paraventricular nucleus (36).

Estrogen may influence developing SOM neurons in the PeN in a nongenomic or indirect manner. A number of different neuronal cell populations innervate hypophysiotropic SOM neurons (37) and could conceivably be involved in the transsynaptic mediation of estrogen’s sexually differentiating actions. As aromatase is found concentrated in the preoptic area, ventromedial nucleus, and amygdala of the neonatal rat (38), neurons projecting from these regions to the SOM cells may be particularly important. In this respect it is noteworthy that GHRH neurons are located near aromatase-expressing cells (38), that they express ERs (39), and that GHRH stimulates SOM mRNA expression (40). As GH itself is involved in the feedback regulation of SOM biosynthesis in the PeN (41, 42), an additional possibility is that estrogen may cause the sexually dimorphic pattern of neonatal SOM mRNA expression by engendering sex differences in the GH feedback mechanism (43, 44).

It is interesting to note that we have detected a sexually dimorphic pattern of AR expression within SOM neurons of the PeN on P5. This result is very similar both qualitatively and quantitatively to that reported by us for adult rats (15) and suggests that this sexually dimorphic pattern of AR expression is generated before P5 and remains unchanged into adulthood. It is not clear what function this sexually dimorphic AR expression serves. Certainly, we seem to have excluded a role for AR-mediated mechanisms in the neonatal organization of sex differences in SOM mRNA expression. As the direct AR-dependent activation of SOM mRNA expression in the PeN of the adult male rat is involved in the generation of the male-type pattern of GH secretion (3, 7, 13, 15, 45), it may be that the sex differences in AR synthesis by SOM neurons are determined during the neonatal period in preparation for their role in the adult. Although such reasoning must remain speculative, it is intriguing to note that a striking developmental switch occurs in the steroid receptor mechanism regulating SOM mRNA expression within the PeN; in the neonate it is the ER, whereas in the adult it is the AR (13, 14).

Functional significance of neonatal sex differences in SOM neurons
The elevated GH concentrations found at the time of birth fall rapidly over the first 2 weeks of life to reach low levels that remain depressed until the onset of puberty (1, 3, 30, 46). A variety of experimental approaches suggest that the developmental increase in SOM secretion from the PeN plays a role in reducing GH secretion over this early neonatal period; a clear inverse correlation exists between hypothalamic SOM content and GH concentrations (30), GH release from the pituitary begins to be inhibited by SOM in the first neonatal week (46, 47), and the administration of SOM antibodies partially prevents the neonatal fall in GH levels (48). We now support further this concept by showing that an increase in SOM biosynthesis occurs over P1 to P10 in the PeN neurons themselves.

The functional relevance of the sex difference in SOM biosynthesis reported here is less clear in terms of neonatal GH secretion. Despite our observation of greater SOM expression in PeN neurons of the neonatal male, investigators have not noted any sex differences in circulating GH concentrations until the time of puberty (1, 30). Thus, the sexually dimorphic SOM expression engendered by gonadal steroids during the neonatal period may only become functionally relevant after puberty when enhanced SOM secretion by PeN neurons is implicated in defining the male pattern of GH secretion (3, 49). As such, the SOM neurons of the PeN may use the neonatal testosterone surge to trigger molecular events within the cell that, aside from elevating SOM biosynthesis immediately, result in their increased biosynthetic capacity as adults. This hypothesis is supported by the observation that testosterone exposure in the adult can only elevate SOM mRNA content to normal male levels when the animal has been exposed to testosterone as a neonate (10).

In summary, we report here that SOM biosynthesis increases in PeN neurons during the first 10 days of life and that a marked sex difference develops over this time. The elevated levels of SOM mRNA content found in the male result from actions of estrogen after the aromatization of testosterone around P5, but do not appear to involve a direct activation of ER{alpha} within these cells. A sexually dimorphic pattern of AR expression is found to exist in P5 rats, but, in contrast to that in the adult rat, is unlikely to be involved in regulating SOM biosynthesis during the neonatal period. Together, these observations indicate that the early neonatal period is an important time during which the SOM neurons of the PeN become sexually differentiated and that this is very likely to have enduring consequences for SOM neuron function in the adult.


    Acknowledgments
 
Dr. R. J. Bicknell is thanked for critical reading of the manuscript.


    Footnotes
 
1 This work was supported by Medical Research Council Project Grant G940978N. Back

2 Lister Institute-Jenner Fellow. Back

Received July 24, 1997.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Eden S 1979 Age- and sex-related differences in episodic growth hormone secretion in the rat. Endocrinology 105:555–560[Abstract/Free Full Text]
  2. Gabriel SM, Roncancio JR, Ruiz NS 1992 Growth-hormone pulsatility and the endocrine milieu during sexual maturation in male and female rats. Neuroendocrinology 56:619–628[Medline]
  3. Jansson J-O, Eden S, Isaksson O 1985 Sexual dimorphism in the control of growth hormone secretion. Endocr Rev 6:128–150[Abstract/Free Full Text]
  4. Plotsky PM, Vale W 1985 Patterns of growth hormone-releasing factor and somatostatin secretion into the hypophysial-portal circulation of the rat. Science 230:461–463[Abstract/Free Full Text]
  5. Maiter D, Koenig JI, Kaplan LM 1991 Sexually dimorphic expression of the growth hormone-releasing hormone gene is not mediated by circulating gonadal hormones in the adult rat. Endocrinology 128:1709–1716[Abstract/Free Full Text]
  6. Argente J, Chowen JA, Zeitler P, Clifton DK, Steiner RA 1991 Sexual dimorphism of growth hormone-releasing hormone and somatostatin gene-expression in the hypothalamus of the rat during development. Endocrinology 128:2369–2375[Abstract/Free Full Text]
  7. Chowen-Breed JA, Steiner RA, Clifton DK 1989 Sexual dimorphism and testosterone-dependent regulation of somatostatin gene-expression in the periventricular nucleus of the rat brain. Endocrinology 125:357–362[Abstract/Free Full Text]
  8. Jansson J-O, Ekberg S, Isaksson OGP, Eden S 1984 Influence of gonadal steroids on age- and sex-related secretory patterns of growth hormone in the rat. Endocrinology 114:1287–1294[Abstract/Free Full Text]
  9. Jansson J-O, Frohman LA 1987 Differential effects of neonatal and adult androgen exposure on the growth hormone secretory pattern in male rats. Endocrinology 120:1551–1557[Abstract/Free Full Text]
  10. Chowen JA, Argente J, Gonzalez-Parra S, Garcia-Segura LM 1993 Differential-effects of the neonatal and adult sex steroid environments on the organization and activation of hypothalamic growth hormone-releasing hormone and somatostatin neurons. Endocrinology 133:2792–2802[Abstract/Free Full Text]
  11. Jansson J-O, Frohman LA 1987 Inhibitory effect of the ovaries on neonatal androgen imprinting of growth hormone secretion in female rats. Endocrinology 121:1417–1423[Abstract/Free Full Text]
  12. Dohler KD, Wuttke W 1975 Changes with age in levels of serum gonadotropins, prolactin, and gonadal steroids in prepubertal male and female rats. Endocrinology 97:898–907[Abstract/Free Full Text]
  13. Argente J, Chowen-Breed JA, Steiner RA, Clifton DK 1990 Somatostatin messenger RNA in hypothalamic neurons is increased by testosterone through activation of androgen receptors and not by aromatization to estradiol. Neuroendocrinology 52:342–349[Medline]
  14. Zorilla R, Simard J, Rheaume E, Labrie F, Pelletier G 1990 Multihormonal control of pre-pro-somatostatin messenger-RNA levels in the periventricular nucleus of the male and female rat hypothalamus. Neuroendocrinology 52:527–536[Medline]
  15. Herbison AE 1995 Sexually dimorphic expression of androgen receptor immunoreactivity by somatostatin neurons in rat hypothalamic periventricular nucleus and bed nucleus of the stria terminalis. J Neuroendocrinol 7:543–553[CrossRef][Medline]
  16. Almazan G, Lefebvre DL, Zingg HH 1989 Ontogeny of hypothalamic vasopressin, oxytocin and somatostatin gene expression. Dev Brain Res 45:69–75[CrossRef][Medline]
  17. MacLusky NJ, Naftolin F 1981 Sexual differentiation of the central nervous system. Science 211:1294–1311[Abstract]
  18. Kiyama H, Emson PC 1990 Distribution of somatostatin mRNA in the rat nervous system as visualized by a novel non-radioactive in situ hybridization histochemistry procedure. Neuroscience 38:223–244[CrossRef][Medline]
  19. Swanson LW 1992 Brain Maps: Structure of the Rat Brain. Elsevier, Amsterdam
  20. Clarke MJO, Gillies GE 1988 Comparison of peptide release from fetal rat hypothalamic neurones cultured in defined and serum containing media. J Endocrinol 116:349–356[Abstract/Free Full Text]
  21. Crowley WR, Kalra SP 1994 Neonatal exposure to estradiol prevents the expression of ovarian hormone-induced luteinizing-hormone and prolactin surges in adulthood but not antecedent changes in neuropeptide-Y or adrenergic transmitter activity: implications for sexual differentiation of gonadotropin secretion. Brain Res 663:257–265[CrossRef][Medline]
  22. Shughrue PJ, Dorsa DM 1994 Estrogen and androgen differentially modulate the growth-associated protein GAP-43 (neuromodulin) messenger ribonucleic acid in postnatal rat brain. Endocrinology 134:1321–1328[Abstract/Free Full Text]
  23. Bakker J, Baum MJ, Slob AK 1996 Neonatal inhibition of brain estrogen synthesis alters adult neural FOS responses to mating and pheromonal stimulation in the male rat. Neuroscience 74:251–260[CrossRef][Medline]
  24. Prins GS, Birch L, Greene GL 1991 Androgen receptor localization in different cell types of the adult rat prostate. Endocrinology 129:3187–3199[Abstract/Free Full Text]
  25. Al Saati T, Clamens S, Cohen-Knafo E, Faye JC, Prats H, Coindre JM, Wafflart J, Caveriviere P, Bayard F, Delsol G 1993 Production of monoclonal antibodies to human estrogen-receptor protein (ER) using recombinant ER (RER). Int J Cancer 55:651–654[Medline]
  26. Simonian SX, Herbison AE 1997 Differential expression of estrogen receptor and neuropeptide by brainstem A1 and A2 noradrenaline neurons. Neuroscience 76:517–529[CrossRef][Medline]
  27. Herbison AE, Theodosis DT 1993 Absence of estrogen-receptor immunoreactivity in somatostatin (SRIF) neurons of the periventricular nucleus but sexually dimorphic colocalization of estrogen-receptor and SRIF immunoreactivities in neurons of the bed nucleus of the stria terminalis. Endocrinology 132:1707–1714[Abstract/Free Full Text]
  28. Moons L, Cambre M, Marivoet S, Batten TFC, Vanderhaeghen J-J, Ollevier F, Vandesande F 1988 Peptidergic innervation of the adrenocorticotropic hormone (ACTH)- and growth gormone (GH)-producing cells in the pars distalis of the sea bass (Dicentrarchus labrax). Gen Comp Endocrinol 72:171–180[CrossRef][Medline]
  29. Shiosaka S, Takatsuki K, Sakanaka M, Inagaki S, Takagi H, Senba E, Kawai Y, Iada H, Minagawa H, Hara Y, Matsuzaki T, Tohyama M 1982 Ontogeny of somatostatin-containing neuron system of the rat: immunohistochemical analysis. II. Forebrain and diencephalon. J Comp Neurol 204:211–224[CrossRef][Medline]
  30. Walker P, Dussault JH, Alvarado-Urbina G, Dupont A 1977 The development of the hypothalamo-pituitary axis in the neonatal rat: hypothalamic somatostatin and pituitary and serum growth hormone concentrations. Endocrinology 101:782–787[Abstract/Free Full Text]
  31. McCarthy MM, Schlenker EH, Pfaff DW 1993 Enduring consequences of neonatal treatment with antisense oligonucleotides to estrogen receptor messenger ribonucleic acid on sexual differentiation of rat brain. Endocrinology 133:433–439[Abstract/Free Full Text]
  32. Herbison AE, Dye S 1993 Perinatal and adult factors responsible for the sexually dimorphic calcitonin gene-related peptide-containing cell-population in the rat preoptic area. Neuroscience 54:991–999[CrossRef][Medline]
  33. Rhees RW, Shryne JE, Gorski RA 1990 Termination of the hormone-sensitive period for differentiation of the sexually dimorphic nucleus of the preoptic area in male and female rats. Dev Brain Res 52:17–23[CrossRef][Medline]
  34. Kuiper G, Enmark E, Peltohuikko M, Nilsson S, Gustafsson JA 1996 Cloning of a novel estrogen-receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93:5925–5930[Abstract/Free Full Text]
  35. Mosselman S, Polman J, Dijkema R 1996 ER-ß: identification and characterization of a novel human estrogen-receptor. FEBS Lett 392:49–53[CrossRef][Medline]
  36. Simonian SX, Herbison AE 1997 Differential expression of estrogen receptor {alpha} and ß immunoreactivity by oxytocin neurons of rat paraventricular nucleus. J Neuroendocrinol 9:803–806[CrossRef][Medline]
  37. Halasz B 1993 Neuroendocrinology in 1992. Neuroendocrinology 57:1196–1207[Medline]
  38. Shinoda K, Nagano M, Osawa Y 1994 Neuronal aromatase expression in preoptic, strial, and amygdaloid regions during late prenatal and early postnatal development in the rat. J Comp Neurol 343:113–129[CrossRef][Medline]
  39. Shirasu K, Stumpf WE, Sar M 1990 Evidence for direct action of estradiol on growth hormone-releasing factor (GRF) in rat hypothalamus: localization of [3H]estradiol in GRF neurons. Endocrinology 127:344–349[Abstract/Free Full Text]
  40. Aguila MC 1994 Growth hormone-releasing factor increases somatostatin release and mRNA levels in the rat periventricular nucleus via nitric oxide by activation of guanylate cyclase. Proc Natl Acad Sci USA 91:782–786[Abstract/Free Full Text]
  41. Chomczynski P, Downs TR, Frihman LA 1988 Feedback regulation of growth hormone releasing hormone gene expression by growth hormone in rat hypothalamus. Mol Endocrinol 2:236–241[Abstract/Free Full Text]
  42. Rogers KV, Vician L, Steiner RA, Clifton DK 1988 The effect of hypophysectomy and growth hormone administration on pre-prosomatostatin messenger ribonucleic acid in the periventricular nucleus of the rat hypothalamus. Endocrinology 131:958–963[Abstract/Free Full Text]
  43. Carlsson LMS, Clark RG, Robinson ICAF 1990 Sex difference in growth hormone feedback in the rat. J Endocrinol 126:27–35[Abstract/Free Full Text]
  44. Maiter DM, Gabriel SM, Koenig JI, Russell WE, Martin JB 1990 Sexual differentiation of growth hormone feedback effects on hypothalamic growth hormone-releasing hormone and somatostatin. Neuroendocrinology 51:174–180[Medline]
  45. Millard WJ, Politch JA, Martin JB, Fox TO 1986 Growth hormone-secretory patterns in androgen-resistant (testicular feminized) rats. Endocrinology 119:2655–2660[Abstract/Free Full Text]
  46. Rieutort M 1981 Ontogenetic development of the inhibition of growth hormone release by somatostatin in the rat: in vivo and in vitro (perifusion) study. J Endocrinol 89:355–363[Abstract/Free Full Text]
  47. Wehrenberg WB 1986 The role of growth hormone-releasing factor and somatostatin on somatic growth in rats. Endocrinology 118:489–494[Abstract/Free Full Text]
  48. Oliver C, Giraud P, Lissitzky JC, Cote J, Boudouresque F, Gillioz P, Conte-Devolx B 1982 Influence of endogenous somatostatin on growth hormone and thyrotropin secretion in neonatal rats. Endocrinology 110:1018–1024[Abstract/Free Full Text]
  49. Tannenbaum GS, Ling N 1984 The interrelationship of growth hormone (GH)-releasing factor and somatostatin in generation of the ultradian rhythm of GH secretion. Endocrinology 115:1952–1957[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
EndocrinologyHome page
C. Orikasa, Y. Kondo, and Y. Sakuma
Transient Transcription of the Somatostatin Gene at the Time of Estrogen-Dependent Organization of the Sexually Dimorphic Nucleus of the Rat Preoptic Area
Endocrinology, March 1, 2007; 148(3): 1144 - 1149.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
R. M. Facciolo, M. Madeo, R. Alo, M. Canonaco, and F. Dessi-Fulgheri
Neurobiological Effects of Bisphenol A May Be Mediated by Somatostatin Subtype 3 Receptors in Some Regions of the Developing Rat Brain
Toxicol. Sci., December 1, 2005; 88(2): 477 - 484.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
G. Diaz-Torga, C. Feierstein, C. Libertun, D. Gelman, M. A. Kelly, M. J. Low, M. Rubinstein, and D. Becu-Villalobos
Disruption of the D2 Dopamine Receptor Alters GH and IGF-I Secretion and Causes Dwarfism in Male Mice
Endocrinology, April 1, 2002; 143(4): 1270 - 1279.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. Kamegai, H. Tamura, T. Shimizu, S. Ishii, H. Sugihara, and I. Wakabayashi
Estrogen Receptor (ER){{alpha}}, But Not ER{beta}, Gene Is Expressed in Growth Hormone-Releasing Hormone Neurons of the Male Rat Hypothalamus
Endocrinology, February 1, 2001; 142(2): 538 - 543.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
F. P. M. Kruijver, J.-N. Zhou, C. W. Pool, M. A. Hofman, L. J. G. Gooren, and D. F. Swaab
Male-to-Female Transsexuals Have Female Neuron Numbers in a Limbic Nucleus
J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 2034 - 2041.
[Abstract] [Full Text]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Simonian, S. X.
Right arrow Articles by Herbison, A. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Simonian, S. X.
Right arrow Articles by Herbison, A. E.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals